TOIIX | VDVIX | TOIIX / VDVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 11 years | - |
Gain YTD | 3.224 | 7.819 | 41% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109M | 204B | 0% |
Annual Yield % from dividends | 1.82 | 3.17 | 58% |
Returns for 1 year | 9.89 | 14.53 | 68% |
Returns for 3 years | -9.38 | 0.44 | -2,145% |
Returns for 5 years | 9.97 | 26.85 | 37% |
Returns for 10 years | N/A | 33.71 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 44.61 | 0.28 | +0.63% |
SPDR® S&P Pharmaceuticals ETF | |||
IHE | 71.92 | -0.02 | -0.03% |
iShares US Pharmaceuticals ETF | |||
JUNW | 29.25 | -0.02 | -0.07% |
AllianzIM U.S. Large Cp Buffer20 Jun ETF | |||
TOLL | 33.41 | -0.08 | -0.23% |
Tema Monopolies and Oligopolies ETF | |||
XLG | 46.22 | -0.18 | -0.39% |
Invesco S&P 500® Top 50 ETF |